Table 1.

Results of gene set enrichment analysis for PFS

LeftRight
NESFDRNESFDR
Good prognosisVasculature development−2.6440.022Organonitrogen compound biosynthetic process−2.9140.002
Extracellular structure organization−2.6170.022Translational initiation−2.7130.011
Blood vessel morphogenesis−2.6640.028Leukocyte migration−2.4190.054
Chromatin modification−2.7350.029Amide biosynthetic process−2.4210.067
Chromatin organization−2.4890.046Peptide metabolic process−2.4440.075
Angiogenesis−2.4510.050Cellular amide metabolic process−2.3280.083
Regulation of vasculature development−2.3860.066Dicarboxylic acid metabolic process−2.2240.115
Skeletal muscle organ development−2.3420.079Acute inflammatory response−2.2110.115
Multicellular organism metabolic process−2.2970.097Small-molecule metabolic process−2.2290.125
Multicellular organismal macromolecule metabolic process−2.1930.146Organonitrogen compound metabolic process−2.2350.137
Regulation of blood circulation−2.1930.159Response to prostaglandin−2.1320.158
Chromatin remodeling−2.2030.165G protein–coupled receptor signaling pathway−2.1140.164
Regulation of cellular component movement−2.1370.170Cell chemotaxis−2.1360.169
Circulatory system development−2.1200.177
Regulation of gene expression epigenetic−2.1110.177
Inflammatory response−2.1390.179
Bad prognosisCell-cycle phase transition2.7250.026
Nucleoside monophosphate biosynthetic process2.5000.068
Cell-cycle G1–S phase transition2.2420.201
Protein dephosphorylation2.2690.225
  • Abbreviation: NES, normalized enrichment score.